Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse

YuHong Fu1, Zoltán Rusznák2, John B J Kwok1

  • 1Neuroscience Research Australia, Sydney, NSW, Australia School of Medical Science, The University of New South Wales, Sydney, NSW, Australia.

Insights

Early Alzheimer's disease (AD) signs in J20 mice include reduced cell proliferation and impaired neurogenesis, occurring before amyloid-β (Aβ) deposits appear. Mutant human amyloid-β protein precursor (hAβPP) overexpression triggers these early pathological events.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • The J20 mouse model overexpresses human mutant amyloid-β protein precursor (hAβPP) and exhibits Alzheimer's disease (AD) features.
  • Amyloid-β (Aβ) deposits and AD-associated changes emerge in J20 mice around 5 months of age.
  • Pre-plaque pathological alterations in the J20 mouse hippocampus remain largely uncharacterized.

Purpose of the Study:

  • To investigate cellular composition and proliferative capacity changes in the J20 mouse hippocampus before Aβ deposition.
  • To identify early, transgene-associated alterations in the J20 mouse model of Alzheimer's disease.

Main Methods:

  • Utilized the isotropic fractionator method to quantify neuronal, non-neuronal, proliferating (Ki-67+), and apoptotic (TUNEL+) cells in J20 mice aged 1-18 months.
  • Assessed age-dependent expression of microglia, astrocyte, and neurogenesis markers throughout the hippocampus.
  • Correlated cell proliferation rates with age and apoptosis markers.

Main Results:

  • Reduced cell proliferation and increased microglia cluster formation observed as early as 4 weeks of age in J20 mice.
  • Impaired neurogenesis detected in the dentate gyrus of 7-11-week-old J20 mice.
  • A steeper age-dependent decline in cell proliferation was noted in wild-type compared to J20 mice, with increased apoptosis in J20 mice.

Conclusions:

  • Overexpression of mutant hAβPP initiates a cascade of pathological events preceding visible Aβ plaque formation.
  • Early indicators of Alzheimer's disease in this model include diminished cell proliferation, compromised neurogenesis, and heightened microglial activity.
  • These findings highlight the importance of studying pre-plaque stages in Alzheimer's disease pathogenesis.

Related Concept Videos